CoVac-1, a new vaccine against SARS-CoV-2, induced T-cell immune responses in 93 percent of patients with B-cell deficiencies, including many patients with leukemia and lymphoma, according to results presented at the AACR ...
Apr 12, 2022
0
6
For severely immunocompromised patients, a bone marrow transplant restores immune defenses and allows them to resume normal life. But after observing the nasopharyngeal system, where the body's first line of immune defense ...
Apr 4, 2022
0
4
On March 29 the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) approved the use of a second COVID-19 booster shot for adults over age 50 and certain immunocompromised individuals, ...
Mar 30, 2022
0
14
A team of scientists at the Yale Schools of Medicine and Public Health has identified a remdesivir-resistant variant of SARS-CoV-2, the virus that causes COVID-19, in an immunocompromised patient who was being treated with ...
Mar 23, 2022
0
131
Spare a thought for patients with impaired immunity during the COVID-19 pandemic. Their condition puts them at high risk of severe complications from COVID-19, but also creates uncertainty about the safety and effectiveness ...
Mar 17, 2022
0
10
Additional doses of COVID-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.
Mar 2, 2022
0
10
It's relatively rare to be hospitalized after getting vaccinated against COVID-19, but those who do typically have significant health issues that contribute to their risk.
Feb 17, 2022
0
7
As the U.S. enters its third year of the pandemic, COVID-19 cases are at an all-time high thanks to the highly transmissible omicron variant.
Jan 5, 2022
0
11
On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which protects against COVID-19, discovered ...
Dec 13, 2021
0
4
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows immunocompromised patients using rituximab (a drug used to treat diseases like rheumatoid arthritis) were able ...
Nov 2, 2021
0
9
